Literature DB >> 20173289

The association of plasma fatty acids with prostate cancer risk in African Americans and Africans.

Flora A Ukoli1, Jay H Fowke, Phillip Akumabor, Temple Oguike, Khandaker A Taher, Harvey J Murff, Emeka R Amaefuna, Rick Kittles, Chiledum Ahaghotu, Usifo Osime, Derrick J Beech.   

Abstract

Higher risk for prostate cancer (PCa) among African Americans is partly associated with exposure to dietary fatty-acids, the carcinogenic effects of which remain controversial. Odds ratio of PCa risk was determined by unconditional logistic regression comparing highest with lowest quartiles of plasma fatty-acids in a case-control design. Mean age for 173 African Americans and 340 Nigerians was 56.9 +/- 9.8 and 60.1 +/- 14.0, p<.006, median (25th, 75th percentile) plasma fatty-acid was 2598 (2306, 3035) microg/ml and 2420 (2064, 2795) microg/ml, p<.001, with 48 (27.7%) and 66 (19.4%) PCa cases, respectively. African Americans recorded higher total, omega-6, and trans, but lower saturated and omega-3 fatty-acids, with non-significant PCa risk association for total, omega-6 and trans fatty acids. Positive PCa risk trend was observed in both populations with nervonic, erucic, and arachidonic acids, with docosahexaenoic acid (DHA) among African Americans, and with behenic and stearic acids in Nigerians. Non-significant negative PCa risk trend was observed with ecosapentaenoic acid (EPA) in Nigerians only. These preliminary findings need to be further explored in a larger study that will include risk analysis of fatty-acid ratios to clarify their combined impact on PCa risk.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173289     DOI: 10.1353/hpu.0.0242

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  8 in total

Review 1.  Omega-3 fatty acids: a growing ocean of choices.

Authors:  Hassan Fares; Carl J Lavie; James J DiNicolantonio; James H O'Keefe; Richard V Milani
Journal:  Curr Atheroscler Rep       Date:  2014-02       Impact factor: 5.113

2.  Blood levels of saturated and monounsaturated fatty acids as markers of de novo lipogenesis and risk of prostate cancer.

Authors:  Jorge E Chavarro; Stacey A Kenfield; Meir J Stampfer; Massimo Loda; Hannia Campos; Howard D Sesso; Jing Ma
Journal:  Am J Epidemiol       Date:  2013-08-28       Impact factor: 4.897

3.  Polymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descent.

Authors:  Emanuela Taioli; Vestra Sears; Alexis Watson; Rafael E Flores-Obando; Maria D Jackson; Flora A Ukoli; Ilce M de Syllos Cólus; Pedro Fernandez; Norma McFarlane-Anderson; Elaine A Ostrander; Iara S Rodrigues; Janet L Stanford; Jack A Taylor; Marshall Tulloch-Reid; Camille C R Ragin
Journal:  Prostate       Date:  2012-11-05       Impact factor: 4.104

4.  The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: A meta-analysis.

Authors:  Michael E Chua; Maria Christina D Sio; Mishell C Sorongon; Marcelino L Morales
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

Review 5.  Prostate cancer chemoprevention in men of African descent: current state of the art and opportunities for future research.

Authors:  Ganna Chornokur; Nagi B Kumar
Journal:  Cancer Causes Control       Date:  2013-06-05       Impact factor: 2.506

6.  Blood level omega-3 Fatty acids as risk determinant molecular biomarker for prostate cancer.

Authors:  Mishell Kris Sorongon-Legaspi; Michael Chua; Maria Christina Sio; Marcelino Morales
Journal:  Prostate Cancer       Date:  2013-03-25

Review 7.  Arachidonic acid and cancer risk: a systematic review of observational studies.

Authors:  Mai Sakai; Saki Kakutani; Chika Horikawa; Hisanori Tokuda; Hiroshi Kawashima; Hiroshi Shibata; Hitomi Okubo; Satoshi Sasaki
Journal:  BMC Cancer       Date:  2012-12-19       Impact factor: 4.430

Review 8.  Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review.

Authors:  Monique Aucoin; Kieran Cooley; Christopher Knee; Heidi Fritz; Lynda G Balneaves; Rodney Breau; Dean Fergusson; Becky Skidmore; Raimond Wong; Dugald Seely
Journal:  Integr Cancer Ther       Date:  2016-06-29       Impact factor: 3.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.